Stream every public session from the 27th annual Global Conference right here on our website.

Watch Here
results for:

Content Type

Centers and Programs

Topics

Tags

Refine by Date

8
Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief report
Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief
The Milken Institute Center for Public Health and FasterCures have identified three PAHPA 2023 poli
cy priorities that are core to improving and strengthening the nation’s biosecurity and preparedness infrastructure.
Jul 21, 2023
Coalition-Building between the US and China on Women’s Cancer Detection, Treatment, and Care report
Coalition-Building between the US and China on Women’s Cancer Detection, Treatment, and Care
Cancer is one of the leading causes of death in the US and China. Of the top 10 (by incidence) canc
ers in China, four are women’s cancers, including breast and cervical cancers.
Jul 16, 2024
An Update from MI Health—July 2024 article
An Update from MI Health—July 2024
In This Issue:
Jul 17, 2024
FasterCures Quarterly Update—July 2024 article
FasterCures Quarterly Update—July 2024
In This Newsletter Highlights from Global Conference Recent Publications Policy Updates FasterCures
Program Updates
Jul 11, 2024
Milken Institute Statement on Newly Released FDA Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials article
Milken Institute Statement on Newly Released FDA Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials
The Milken Institute celebrates the publication of the second iteration of the Food and Drug Adminis
tration (FDA) draft guidance on Diversity Action Plans (DAP) to improve clinical trial diversity by enrolling underrepresented populations in the US.
Jul 1, 2024
Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870 article
Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
Submitted electronically Dr. Robert Califf Commissioner US Food and Drug Administration Silver Spri
ng, MD 20993 Dear Dr. Califf,
Jul 31, 2023
World Leaders to Descend on Singapore for the 10th Milken Institute Asia Summit, Celebrating a Decade of Progress, Action, and Impact article
World Leaders to Descend on Singapore for the 10th Milken Institute Asia Summit, Celebrating a Decade of Progress, Action, and Impact
August 1, 2023 (SINGAPORE) - The annual Milken Institute Asia Summit, taking place from September 13
– 15, will convene regional and global leaders to dis
Jul 31, 2023
FasterCures Quarterly Update: July 2023 article
FasterCures Quarterly Update: July 2023
In This Issue: Convenings Recap Policy Updates FasterCures in the Media FasterCures in the Communit
y
Jul 13, 2023